Neonatal encephalopathy is a leading cause of death and disability in newborns. Therapeutic hypothermia has been shown to reduce the risk of disability if applied within the first six hours after birth. However, identifying newborns who may benefit from this therapy is challenging and has led to variation in its application.
Our expert faculty will share their perspectives on implementing the guidelines into their practices, discuss their experiences, challenges, and successes they encountered while applying the guidelines in each of their institutions.
Upon completion of this activity, participants will be able to:
Continuing Medical Education
CRICO/Risk Management Foundation of the Harvard Medical Institutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CRICO/RMF designates this enduring material for a maximum of 1.0 AMA PRA Category I Credit™
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designed to be suitable for 1.0 hours of Risk Management study in Massachusetts.